BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38522066)

  • 1. Leveraging Systematic Reviews to Explore Disease Burden and Costs of Per- and Polyfluoroalkyl Substance Exposures in the United States.
    Obsekov V; Kahn LG; Trasande L
    Expo Health; 2023; 15(2):373-394. PubMed ID: 37213870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segmentation of Renal Thyroid Follicle Colloid in Common Carp: Insights into Perfluorooctanoic Acid-Induced Morphometric Alterations.
    Manera M; Giari L
    Toxics; 2024 May; 12(5):. PubMed ID: 38787148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroalkyl Chemicals and Male Reproductive Health: Do PFOA and PFOS Increase Risk for Male Infertility?
    Tarapore P; Ouyang B
    Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33916482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing the structure of PFOA and PFOS: a chemical industry strategy or a solution to avoid thyroid-disrupting effects?
    Coperchini F; Greco A; Rotondi M
    J Endocrinol Invest; 2024 Mar; ():. PubMed ID: 38522066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing potency factors for thyroid hormone disruption by PFASs using TTR-TRβ CALUX® bioassay and assessment of PFASs mixtures in technical products.
    Behnisch PA; Besselink H; Weber R; Willand W; Huang J; Brouwer A
    Environ Int; 2021 Dec; 157():106791. PubMed ID: 34364217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro.
    Coperchini F; Croce L; Pignatti P; Ricci G; Gangemi D; Magri F; Imbriani M; Rotondi M; Chiovato L
    J Endocrinol Invest; 2021 Aug; 44(8):1625-1635. PubMed ID: 33315184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Evaluation of the Effects of Legacy and New Generation Perfluoralkyl Substances (PFAS) on Thyroid Cells
    De Toni L; Di Nisio A; Rocca MS; Pedrucci F; Garolla A; Dall'Acqua S; Guidolin D; Ferlin A; Foresta C
    Front Endocrinol (Lausanne); 2022; 13():915096. PubMed ID: 35813651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid Disrupting Effects of Old and New Generation PFAS.
    Coperchini F; Croce L; Ricci G; Magri F; Rotondi M; Imbriani M; Chiovato L
    Front Endocrinol (Lausanne); 2020; 11():612320. PubMed ID: 33542707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to perfluoroalkyl substances (PFAS) and association with thyroid hormones in adolescent males.
    Freire C; Vela-Soria F; Castiello F; Salamanca-Fernández E; Quesada-Jiménez R; López-Alados MC; Fernandez MF; Olea N
    Int J Hyg Environ Health; 2023 Jul; 252():114219. PubMed ID: 37451108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
    Madrigal JM; Troisi R; Surcel HM; Öhman H; Kivelä J; Kiviranta H; Rantakokko P; Koponen J; Medgyesi DN; Kitahara CM; McGlynn KA; Sampson J; Albert PS; Ward MH; Jones RR
    Int J Cancer; 2024 Mar; 154(6):979-991. PubMed ID: 37902275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Per- and polyfluoroalkyl substances (PFAS) exposure and thyroid cancer risk.
    van Gerwen M; Colicino E; Guan H; Dolios G; Nadkarni GN; Vermeulen RCH; Wolff MS; Arora M; Genden EM; Petrick LM
    EBioMedicine; 2023 Nov; 97():104831. PubMed ID: 37884429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid dysfunction and female infertility. A comprehensive review.
    Concepción-Zavaleta MJ; Coronado-Arroyo JC; Quiroz-Aldave JE; Concepción-Urteaga LA; Paz-Ibarra J
    Diabetes Metab Syndr; 2023 Nov; 17(11):102876. PubMed ID: 37866272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borderline personality disorder and thyroid diseases: a Mendelian randomization study.
    Wang Q; Li P; Qi S; Yuan J; Ding Z
    Front Endocrinol (Lausanne); 2023; 14():1259520. PubMed ID: 37854187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthyroidism: A Review.
    Lee SY; Pearce EN
    JAMA; 2023 Oct; 330(15):1472-1483. PubMed ID: 37847271
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.